{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:06Z","timestamp":1786997886417,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":380,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.vhri.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T16:32:44Z","timestamp":1443198764000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia in Guatemala"],"prefix":"10.1016","volume":"8","author":[{"given":"Benjamin Cruz","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Calvimontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2015.06.002_bib1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMcp1111259","article-title":"Evaluation and initial treatment of supraventricular tachycardia","volume":"367","author":"Link","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vhri.2015.06.002_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population","volume":"31","author":"Orejarena","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vhri.2015.06.002_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0002-9343(97)89495-8","article-title":"The present role of radiofrequency catheter ablation in the management of cardiac arrhythmias","volume":"100","author":"Kay","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.vhri.2015.06.002_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00246-006-1220-8","article-title":"Radiofrequency catheter ablation of supraventricular tachycardia in children and adolescents: feasibility and cost-effectiveness in a low-income country","volume":"27","author":"Vida","year":"2006","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.vhri.2015.06.002_bib5","unstructured":"The World Bank. Principal global indicators. Available from: http:\/\/data.worldbank.org\/country\/guatemala. [Accessed March 29, 2014]."},{"key":"10.1016\/j.vhri.2015.06.002_bib6","unstructured":"National Institute of Statistics of Guatemala. INE proyecciones 2008-2020. Available from: http:\/\/www.ine.gob.gt\/index.php\/estadisticas\/tema-indicadores. [Accessed March 29, 2014]."},{"key":"10.1016\/j.vhri.2015.06.002_bib7","first-page":"II437","article-title":"Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome","volume":"88","author":"Hogenhuis","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.vhri.2015.06.002_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.7326\/0003-4819-133-11-200012050-00010","article-title":"Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia","volume":"133","author":"Cheng","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vhri.2015.06.002_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.CIR.101.3.280","article-title":"Cost-effectiveness of catheter ablation in patients with ventricular tachycardia","volume":"101","author":"Calkins","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vhri.2015.06.002_bib10","first-page":"461","article-title":"Cost effectiveness of radiofrequency catheter ablation versus medical treatment for paroxysmal supraventricular tachycardia in Japan","volume":"24","author":"Ikeda","year":"1994","journal-title":"J Cardiol"},{"key":"10.1016\/j.vhri.2015.06.002_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0002-9149(98)00416-0","article-title":"Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs","volume":"82","author":"Bathina","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.vhri.2015.06.002_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9149(99)00338-0","article-title":"Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia","volume":"84","author":"Larson","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.vhri.2015.06.002_bib13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/0735-1097(92)90621-S","article-title":"Comparison of the cost of radiofrequency catheter modification of the atrioventricular node and medical therapy for drug-refractory atrioventricular node reentrant tachycardia","volume":"19","author":"Kalbfleisch","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vhri.2015.06.002_bib14","article-title":"Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators","volume":"70:11","author":"Anderson","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.vhri.2015.06.002_bib15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/clpt.1992.63","article-title":"Treatment of paroxysmal supraventricular tachycardia with oral diltiazem","volume":"51","author":"Clair","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vhri.2015.06.002_bib16","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Meheran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.vhri.2015.06.002_bib17","series-title":"CHOosing Interventions that are Cost Effective (WHO-CHOICE)","year":"1998"},{"key":"10.1016\/j.vhri.2015.06.002_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCEP.108.837294","article-title":"Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation","volume":"2","author":"Reynolds","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109915000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109915000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T02:31:02Z","timestamp":1537324262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109915000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":18,"alternative-id":["S2212109915000485"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2015.06.002","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia in Guatemala","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}